R. J. Bateman - School of Medicine, Washington University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes Towards Future Clinical Trials

Haiyan Liu,J. Li, E. Ziegemeier, S. Adams,E. McDade,D. B. Clifford, Y. Cao, G. Wang, Y. Li, S. L. Mills,A. M. Santacruz,S. Belyew,J. D. Grill, B. J. Snider,C. J. Mummery, G. Surti,D. Hannequin,D. Wallon,S. B. Berman, I. Z. Jimenez-Velazquez,E. D. Roberson,C. H. van Dyck,L. S. Honig,R. Sanchez-Valle,W. S. Brooks,S. Gauthier,D. Galasko,C. L. Masters, J. Brosch,G.-Y. R. Hsiung,S. Jayadev,M. Formaglio,M. Masellis,R. Clarnette,J. Pariente,B. Dubois,F. Pasquier,R. J. Bateman,Jorge J. Llibre-Guerra

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEno. 3 (2024): 558-566

引用0浏览0WOS引用

Can We Use Blood Biomarkers As Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force

D. Angioni,O. Hansson,R. J. Bateman, C. Rabe, M. Toloue,J. B. Braunstein, S. Agus,J. R. Sims,T. Bittner,M. C. Carrillo,H. Fillit,C. L. Masters,S. Salloway,P. Aisen,M. Weiner,B. Vellas,S. Gauthier,Susan Abushakra,Mohammad Afshar,John Alam,Alicia Algeciras-Schimnich,Sandrine Andrieu,Clive Ballard, Amos Baruch,Richard Batrla,Monika Baudler,Joanne Bell,Sasha Bozeat,Dawn Brooks, Tricia Brooks,Szofia Bullain, Jan Burmeister,Min Cho,Emily Collins, Gavin Cook,Jeffrey Cummings, Chris Dague,Susan De Santi,Rachelle Doody,Billy Dunn,Michael Egan,Sven Eriksson,Rianne Esquivel,Tom Fagan,Phyllis Ferrell,Michela Gallagher, Anna-Kaija Grönblad, Avis Hains,Harald Hampel,Nanco Hefting,Suzanne Hendrix,Carole Ho,Helen Hu,Zahinoor Ismail,Daryl Jones,Gene Kinney,Paul Kinnon,Ricky Kurzman,Lars Lannfelt,John Lawson, Nathalie LeBastard,Valérie Legrand, Nicole Lewandowski, Carine Lim, Costantine Lyketsos,Donna Masterman,Ming Lu,Mark Mintun,José Luis Molinuevo,Cecilia Monteiro,Bradford Navia,Tomas Odergren,Gunilla Osswald,Lewis Penny,Michael Pontecorvo,Anton Porsteinsson,Rema Raman,Gesine Respondek,Larisa Reyderman, Sharon Rogers,Paul Rosenberg,Sharon Rosenzweig-Lipson, Mark Roskey,Rubel Carrie,Ziad Saad,Rachel Schindler,Dennis Selkoe,Melanie Shulman,Kaycee Sink, Lisa Sipe,Daniel Skovronsky,Elizabeth Somers,Maria Soto,Johannes Streffer,Pedro Such,Joyce Suhy,Jacques Touchon,Manu Vandijck, Anne White, David Wilson,Wagner Zago, Jin Zhou

The Journal of prevention of Alzheimer's disease/JPAD (2023)

引用2浏览0WOS引用

Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease

L. Vermunt, C. Sutphen,E. Dicks, D.M. de Leeuw,R. Allegri,S.B. Berman,D.M. Cash,J.P. Chhatwal,C. Cruchaga,G. Day,M. Ewers,M. Farlow,N.C. Fox,B. Ghetti,N. Graff-Radford,J. Hassenstab,M. Jucker,C M. Karch,J. Kuhle,C. Laske, J. Levin,C.L Masters,E. McDade, H. Mori, J.C. Morris,R.J. Perrin, O. Preische,P.R. Schofield,M. Suárez-Calvet,C. Xiong,P. Scheltens,C.E. Teunissen,P.J. Visser,R.J. Bateman,T.L.S. Benzinger,A.M. Fagan,B.A. Gordon,B.M. Tijms,the Dominantly Inherited Alzheimer Network.

medrxiv（2023）

引用0浏览0引用

The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report

Julien Delrieu,R. J. Bateman,J. Touchon,M. Sabbagh,J. Cummings

The Journal of Prevention of Alzheimer's Diseaseno. 3 (2022): 393-399

引用7浏览0WOS引用

Platform Trials to Expedite Drug Development in Alzheimer’s Disease: A Report from the EU/US CTAD Task Force

University of Southern California Alzheimer’s Therapeutic Research Institute,Bateman R. J.,Carrillo M.,Doody R.,Johnson K.,Sims J. R.,Sperling R.,Vellas B.

The Journal of Prevention of Alzheimer's Disease（2021）

引用17浏览0WOS引用

Prospective Associations Between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults

Lu Wan-Hsuan,Giudici K. V., University of Toulouse III, Li Y.,Bateman R. J.

The Journal of Prevention of Alzheimer s Disease（2020）

引用3浏览0WOS引用

ABBV-8E12, a humanized anti-tau monoclonal antibody for the treatment of early Alzheimer's disease and psp: updated design and baseline characteristics of phase 2 studies

N. Mendonca,R. J. Bateman,J. B. Braunstein,K. Budur,D. M. Holtzman,B. Rendenbach-Mueller,W. Robieson,H. Soares,D. Wang,H. Florian

EUROPEAN JOURNAL OF NEUROLOGY（2019）

引用0浏览0引用

Anti-Tau Trials for Alzheimer’s Disease: A Report from the EU/US/CTAD Task Force

Jeffrey Cummings,K. Blennow,K. Johnson,M. Keeley,R. J. Bateman,J. L. Molinuevo,J. Touchon,P. Aisen,B. Vellas

J Prev Alzheimers Dis（2019）

引用48浏览0WOS引用

ABBV-8E12, a humanized anti-Tau monoclonal antibody for the treatment of Early Alzheimer's Disease and PSP: multiple dose, randomized, double-blind, placebo-controlled phase-2 studies

N. Mendonca,H. Florian,D. Wang,W. Robieson,H. Soares,J. B. Braunstein,D. M. Holtzman,R. J. Bateman,B. Rendenbach-Mueller,K. Budur

EUROPEAN JOURNAL OF NEUROLOGY（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn